Keyword: Eli Lilly

Strategy & Management

Continuous Processing

10.09.2019 - Is it possible to learn from other industries or are we doomed to repeat the same mistakes in the pharma sector? Not long ago, I came across a Forbes article which described how...

News

Lilly Wins Alimta Appeal

23.08.2019 - US pharma company Eli Lilly has won a federal appeals court decision that protects its cancer drug Alimta from generic versions made by Pfizer and Dr. Reddy’s Laboratories. The US...

News

Bayer and Elanco Animal Health Link-up?

18.07.2019 - Pharmaceutical market buzz last month had it that private equity investors in Europe and the US were lining up to buy the animal health business Bayer is preparing for sale to pare...

News

Lilly and Avidity Biosciences Partner on New Drugs

30.04.2019 - Eli Lilly is collaborating with Avidity Biosciences to discover, develop and commercialize potential new medicines in immunology and other select indications. The companies will...

Strategy & Management

The Need for Innovation in Pharmaceutical Manufacturing

08.04.2019 - The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious...

News

Lilly Launches cut-price Generic Insulin in US

06.03.2019 - Under the name Insulin Lispro, US drugmaker Eli Lilly plans to sell a generic version of its rapid-acting insulin Humalog. It will be priced 50% below the name-brand product, which...

News

Eli Lilly to Buy Loxo for $8 Billion

09.01.2019 - In the latest move by “big pharma” to buy into cancer-focused biotechs, US drugmaker Eli Lilly is acquiring Loxo Oncology for about $8 billion in cash. The plans were announced on...

News

DCAT Announces New Board of Directors

02.11.2018 - Paolo Magri, senior vice president, business development at Advitech, has been elected president of the Drug, Chemical & Associated Technologies Association (DCAT). Also elected to...